author-photo

William O'Riordan

AmeriCorps VISTA

41

Papers

1874

Citations

Citation Trend

Filter By

Papers (29) Sort By

Journal Conference Others

ILLUMINATE-A, une étude de phase 3 du lumasiran, un ARNi thérapeutique expérimental, chez les enfants et les adultes atteints d’hyperoxalurie primaire de type 1

2020 Nephrologie & Therapeutique
Show All
- Source
- Cite
- Save
Citations (0)
The Consumer Education Journey

2020
- Rebin Naderi
- William O'Riordan
Show All
- Source
- Cite
- Save
Citations (0)
A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections

2020 Journal of Medical Microbiology
Show All
- Source
- Cite
- Save
Citations (1)
LB002ILLUMINATE-A, A PHASE 3 STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN CHILDREN AND ADULTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)

2020 Nephrology Dialysis Transplantation
Show All
- Source
- Cite
- Save
Citations (8)
P.025 APOLLO, a phase 3 study of patisiran for the treatment of hereditary transthyretin amyloidosis (hATTR): 18-month safety and efficacy in subgroup with cardiac involvement

2019 Canadian Journal of Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (0)
470. Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Patients with Significant Drug Abuse: Outcomes from Global Phase 3 Studies of Delafloxacin (DLX)

2019 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and safety of tedizolid phosphate versus linezolid in a randomized Phase 3 trial in patients with acute bacterial skin and skin structure infection

2019 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (9)
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections

2019 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (67)
Changes in neuropathy stage in patients with hATTR amyloidosis following patisiran treatment : Analysis from APOLLO

2018 Journal of The Peripheral Nervous System
Show All
- Source
- Cite
- Save
Citations (0)
A Phase 3, Randomized, double-blind, multicenter study to EValuate the safety and efficacy of intravenous Iclaprim versus Vancomycin for the trEatment of acute bacterial skin and skin structure infections suspected or confirmed to be due to Gram-positive pathogens: REVIVE-2

2018 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (21)